Home › OLYMPUS MEDICAL SYSTEMS CORP. › PRINTER PAPER ROLL
PRINTER PAPER ROLL
OLYMPUS MEDICAL SYSTEMS CORP. · Model MAJ-1497 · UDI-DI 04953170234071
FEB
Prescription
10
510(k) clearances
5,046
Adverse events (22 deaths)
40
Recalls
22
Facilities
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | XXX |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
